119 related articles for article (PubMed ID: 17475724)
1. Medication access and continuity under Medicare Part D.
Pollack DA
Am J Psychiatry; 2007 May; 164(5):700-1. PubMed ID: 17475724
[No Abstract] [Full Text] [Related]
2. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit.
West JC; Wilk JE; Muszynski IL; Rae DS; Rubio-Stipec M; Alter CL; Narrow WE; Regier DA
Am J Psychiatry; 2007 May; 164(5):789-96. PubMed ID: 17475738
[TBL] [Abstract][Full Text] [Related]
3. Access to Medicare Part D gap coverage more scarce in 2007.
Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
[No Abstract] [Full Text] [Related]
4. Medicare Part D--the product of a broken process.
Slaughter LM
N Engl J Med; 2006 Jun; 354(22):2314-5. PubMed ID: 16738267
[No Abstract] [Full Text] [Related]
5. The rise and fall of national and North Carolina policies addressing medication access for older adults.
Altman HK
N C Med J; 1999; 60(4):198-202. PubMed ID: 10424115
[No Abstract] [Full Text] [Related]
6. The Medicare Modernization Act of 2003, part D.
Simonson W
J Am Med Dir Assoc; 2005; 6(3):231-2. PubMed ID: 15894257
[No Abstract] [Full Text] [Related]
7. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
[TBL] [Abstract][Full Text] [Related]
8. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
9. Some over-the-counter advice on making drug therapy work. Interview by Patrick Mullen.
Gans JA
Manag Care; 2001 Oct; 10(10):41-2, 44, 47. PubMed ID: 11764745
[No Abstract] [Full Text] [Related]
10. Prescription-drug coverage for medicare beneficiaries.
Iglehart JK
N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
[No Abstract] [Full Text] [Related]
11. Clinical pharmacology of the appeals and exception process: the interface of the patient, physician, and insurance company to assure appropriate care under Medicare Part D.
Blum RS
J Clin Pharmacol; 2006 Apr; 46(4):394-7. PubMed ID: 16554444
[TBL] [Abstract][Full Text] [Related]
12. Who'll get soaked if Medicare covers drugs?
Moskowitz DB
Bus Health; 2000; 18(10):33-5, 38. PubMed ID: 11213766
[No Abstract] [Full Text] [Related]
13. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
Emmer S; Allendorf L
J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
[No Abstract] [Full Text] [Related]
14. Clinton proposal begins debate on Medicare prescription benefit.
Weiss HP
Balance; 1999; 3(5):6-7. PubMed ID: 10662381
[No Abstract] [Full Text] [Related]
15. Immediate prescription coverage in doubt for Medicare recipients.
Voelker R
JAMA; 2001 Mar; 285(9):1144. PubMed ID: 11231731
[No Abstract] [Full Text] [Related]
16. In Beltway, all eyes are on drug benefit.
Gardner J
Mod Healthc; 2000 May; 30(21):44. PubMed ID: 11067548
[No Abstract] [Full Text] [Related]
17. Catastrophic health insurance: budget and policy issues.
Helms RB
Am J Pharm Educ; 1989; 53(4):356-9. PubMed ID: 10304253
[No Abstract] [Full Text] [Related]
18. Medicare agreement: premium support demo ... maybe.
Med Health; 2003 Nov; 57(43):1-2. PubMed ID: 14723114
[No Abstract] [Full Text] [Related]
19. Advocating for a Medicare prescription drug benefit.
Rother J
Yale J Health Policy Law Ethics; 2003; 3(2):279-90. PubMed ID: 14577144
[No Abstract] [Full Text] [Related]
20. Drug card setback highlights need for cost relief.
Gundling RL
Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
